Highly regarded for its strong track record advising defendants in large class actions in the life sciences and manufacturing sectors, the antitrust and competition practice at Baker Botts L.L.P. has recently seen an increase in activity relating to algorithmic price-fixing cases in the real estate industry. John Taladay heads the practice and is a seasoned antitrust specialist with an emphasis on merger clearances, bid-rigging, price-fixing, market allocation, and unfair trade practices, particularly in the pharma sector. Paul Cuomo focuses his practice on multijurisdictional merger reviews and litigation, while James Kress takes point on competitor-on-competitor disputes and has a notable track record advising on class certification issues. Erik Koons regularly represents clients in bet-the-company litigations spanning the full range of antitrust issues with a particular focus on price-fixing, market allocation, and monopolization; Koons also co-chairs the firm’s antitrust consumer products sub-group. Christopher Wilson was promoted to partner in March 2023 and focuses on the intersection of IP and antitrust work for clients in the telecoms, manufacturing, healthcare, and pharma sectors. All mentioned individuals are based in Washington DC. Maureen Ohlhausen left the practice in January 2024.
Key clients
- Avenue5 Residential
- Caterpillar Inc.
- CMC Materials, Inc.
- Envista Holdings Corporation
- Ericsson Inc.
- Georgia-Pacific LLC (GP Wood Products LLC)
- Irico Display Devices Co., Ltd.
- Koninklijke Philips N.V., Philips North America LLC, Philips Taiwan, Limited and Philips do Brasil Ltda.
- McKenna & Associates, LLC
- National Association of Boards of Pharmacy
- Philips Respironics
- Safariland
- Sun Pharmaceuticals / Taro Pharmaceuticals
- Waste Management, Inc.
Work highlights
- Representing Sun Pharma and Taro Pharma in In re: Generic Pharmaceuticals Pricing Antitrust Litigation, litigation, billed by plaintiffs as the largest price-fixing cases in history alleging that more than 35 generic pharma manufacturers conspired to inflate the prices of more than 200 generic drugs.
- Representing the National Association of Boards of Pharmacy (NABP) as lead counsel in antitrust litigation filed in the Southern District of New York alleging a Section 1 conspiracy and group boycott among the defendants.
Lawyers
Practice head
The lawyer(s) leading their teams.
John Taladay